RECORD FINANCIAL RESULTS AND MARKET SHARE POSITIONS IN ALL KEY MARKETS
STEP-CHANGING INVESTMENT IN BRAND AND CAPABILITY
Results highlights for the half-year ended 31 December 2018 (NZ$)1
Please click here to view the interim results commentary.
Please click here to view the interim results presentation.
Please click here to view the interim report for the six months ended 31 December 2018.
Please click here to listen to the interim results call.
1All figures are in New Zealand Dollars (NZ$) unless otherwise stated
2All comparisons are with the six months ended 31 December 2017 (1H18), unless otherwise stated
3Earnings before interest, tax, depreciation and amortisation (EBITDA) is a non-GAAP measure. However, the Company believes that it assists in providing investors with a comprehensive understanding of the underlying performance of the business. A reconciliation of EBITDA to net profit after tax is shown at the end of this document
4Kantar Infant Formula market tracking of Tier 1 and Key A cities for 12 months ending 28 December 2018 by value
5Aztec Australian Grocery and Pharmacy Scan 12 months ending 30 December 2018
6Aztec Australian Grocery Weighted Scan 12 months ending 30 December 2018